Welcome to Vitalea Science

Vitalea brings the world’s experts in Accelerator Mass Spectrometry Technology (AMS) to work closely with clients to safely measure pharmacokinetics in humans and more effectively accelerate drug development, while reducing overall costs.

Harnessing the power of the AMS atom counter,  Vitalea provides ADME, bioavailability, and pharmacokinetic evaluations at the very earliest stages of clinical drug development: Phase 0/exploratory IND microdosing and Phase I micro-tracing.  

“Streamlining early clinical development with microdosing and microtracers” enables better development decisions, increasing potential success while reducing costs of failure for new drugs, formulations and delivery strategies.

We are partnered with several clinics in many countries to offer innovative clinical options to your drug development program.  Please visit Our Partners for more information.

We welcome the opportunity to work with you!